A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma

A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma

Abstract Synovial sarcoma (SS) is one of the commonest non-rhabdomyosarcoma soft tissue sarcoma with limited treatment options in the relapsed and advanced settings. The combination of gemcitabine and docetaxel has demonstrated its role predominantly in leiomyosarcoma and pleomorphic sarcomas but ha...

Full description

Bibliographic Details
Main Authors: Ghazal Tansir, Sameer Rastogi, Akash Kumar, Adarsh Barwad, Asit R. Mridha, Ekta Dhamija, Shamim A. Shamim, Sushma Bhatnagar, Sandeep Bhoriwal
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Cancer
Subjects:
Soft tissue sarcoma
Palliative chemotherapy
Synovial sarcoma
Quality of life
Online Access:https://doi.org/10.1186/s12885-023-11099-4

Internet

https://doi.org/10.1186/s12885-023-11099-4

Similar Items